Impact of Obesity on Cardiovascular Disease
作者： Kerstyn C. Zalesin , Barry A. Franklin , Wendy M. Miller , Eric D. Peterson , Peter A. McCullough
DOI: 10.1016/J.ECL.2008.06.004
关键词: Systemic inflammation 、 Obesity 、 Heart failure 、 Epidemiology 、 Atrial fibrillation 、 Type 2 Diabetes Mellitus 、 Intensive care medicine 、 Weight loss 、 Medicine 、 Internal medicine 、 Disease 、 Endocrinology 、 Endocrinology, Diabetes and Metabolism
摘要: The epidemiology of cardiovacular disease risk factors is changing rapidly with the obesity pandemic. Obesity independently associated risks for coronary heart disease, atrial fibrillation, and failure. Intra-abdominal also unique as a cardiovascular state in that it contributes to or directly causes most other modifiable factors, namely, hypertension, dysmetabolic syndrome, type 2 diabetes mellitus. can exacerbate through variety mechanisms including systemic inflammation, hypercoagulability, activation sympathetic renin-angiotensin systems. Thus, weight reduction key strategy simultaneous improvement global risk, anticipated improvements survival quality life.
lenus.ie
elsevier.com
sci-hub.se 参考文章(133)
Eric L. Eisenstein, Linda K. Shaw, Charlotte L. Nelson, Kevin J. Anstrom, Zafar Hakim, Daniel B. Mark, Obesity and Long-Term Clinical and Economic Outcomes in Coronary Artery Disease Patients Obesity Research. ,vol. 10, pp. 83- 91 ,(2002) , 10.1038/OBY.2002.14
B. Isomaa, P. Almgren, T. Tuomi, B. Forsen, K. Lahti, M. Nissen, M.-R. Taskinen, L. Groop, Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome Diabetes Care. ,vol. 24, pp. 683- 689 ,(2001) , 10.2337/DIACARE.24.4.683
Abel Romero-Corral, Victor M Montori, Virend K Somers, Josef Korinek, Randal J Thomas, Thomas G Allison, Farouk Mookadam, Francisco Lopez-Jimenez, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies The Lancet. ,vol. 368, pp. 666- 678 ,(2006) , 10.1016/S0140-6736(06)69251-9
John S. Yudkin, Hyperinsulinaemia, Insulin Resistance, Microalbuminuria and the Risk of Coronary Heart Disease Annals of Medicine. ,vol. 28, pp. 433- 438 ,(1996) , 10.3109/07853899608999104
M. L. Tuck, Obesity, the sympathetic nervous system, and essential hypertension. Hypertension. ,vol. 19, pp. I67- I67 ,(1992) , 10.1161/01.HYP.19.1_SUPPL.I67
Gianluca Iacobellis, Domenico Corradi, Arya M Sharma, Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nature Reviews Cardiology. ,vol. 2, pp. 536- 543 ,(2005) , 10.1038/NCPCARDIO0319
Kelly J. Hunt, Roy G. Resendez, Ken Williams, Steve M. Haffner, Michael P. Stern, National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study Circulation. ,vol. 110, pp. 1251- 1257 ,(2004) , 10.1161/01.CIR.0000140762.04598.F9
Francisco Lopez-Jimenez, Steven J. Jacobsen, Guy S. Reeder, Susan A. Weston, Ryan A. Meverden, Véronique L. Roger, Prevalence and Secular Trends of Excess Body Weight and Impact on Outcomes After Myocardial Infarction in the Community Chest. ,vol. 125, pp. 1205- 1212 ,(2004) , 10.1378/CHEST.125.4.1205
William F Keane, Garabed Eknoyan, None, Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney Foundation American Journal of Kidney Diseases. ,vol. 33, pp. 1004- 1010 ,(1999) , 10.1016/S0272-6386(99)70442-7
Guido Grassi, Gino Seravalle, Raffaella Dell'Oro, Fosca Quarti Trevano, Michele Bombelli, Francesco Scopelliti, Anna Facchini, Giuseppe Mancia, Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. Journal of Hypertension. ,vol. 21, pp. 1761- 1769 ,(2003) , 10.1097/00004872-200309000-00027